{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:49:26Z","timestamp":1790495366315,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"French National Agency"},{"name":"France Recherche Nord & Sud SIDA\u2013HIV H\u00e9patites"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/jac\/dky193","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T19:08:47Z","timestamp":1524856127000},"page":"2120-2128","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacokinetic modelling of darunavir\/ritonavir dose reduction (800\/100 to 400\/100\u2009mg once daily) in a darunavir\/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study"],"prefix":"10.1093","volume":"73","author":[{"given":"Minh P","family":"L\u00ea","sequence":"first","affiliation":[{"name":"IAME, UMR 1137, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 and INSERM, Paris, France"},{"name":"AP-HP, H\u00f4pital Bichat-Claude Bernard, Laboratoire de Pharmacologie-Toxicologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Chaix","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Saint Louis, Laboratoire de Virologie, INSERM U941 - Universit\u00e9 Denis Diderot Paris VII, F-75010 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Saint Louis, SBIM-URC, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bertrand","sequence":"additional","affiliation":[{"name":"IAME, UMR 1137, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 and INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Raffi","sequence":"additional","affiliation":[{"name":"H\u00f4pital Universitaire H\u00f4tel Dieu, Service de Maladies Infectieuses et Tropicales, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gallien","sequence":"additional","affiliation":[{"name":"AP-HP, CHU Henri Mondor, Service d'Immunologie Clinique et Maladies Infectieuses, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Mountacer Billah","family":"El Abbassi","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Saint Louis, SBIM-URC, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Service de Maladies Infectieuses et Tropicales, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Delobel","sequence":"additional","affiliation":[{"name":"CHU de Toulouse, Service de Maladies Infectieuses et Tropicales, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"IAME, UMR 1137, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 and INSERM, Paris, France"},{"name":"AP-HP, H\u00f4pital Bichat-Claude Bernard, Laboratoire de Pharmacologie-Toxicologie, Paris, France"},{"name":"AP-HP, H\u00f4pital Saint Louis, Laboratoire de Virologie, INSERM U941 - Universit\u00e9 Denis Diderot Paris VII, F-75010 Paris, France"},{"name":"AP-HP, H\u00f4pital Saint Louis, SBIM-URC, Paris, France"},{"name":"H\u00f4pital Universitaire H\u00f4tel Dieu, Service de Maladies Infectieuses et Tropicales, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Saillard","sequence":"additional","affiliation":[{"name":"France Recherche Nord & Sud SIDA-HIV H\u00e9patites (ANRS), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Saint Louis, Service de Maladies Infectieuses et Tropicales, INSERM U941, Universit\u00e9 Denis Diderot Paris VII, F-75010 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[{"name":"IAME, UMR 1137, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 and INSERM, Paris, France"},{"name":"AP-HP, H\u00f4pital Bichat-Claude Bernard, Laboratoire de Pharmacologie-Toxicologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ANRS 165 DARULIGHT Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ponscarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lascoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tubiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Jeantils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Loreillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Poizot-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Allavena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Billaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bouchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Reliquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Raffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"De Truchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Charreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Bocquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Lemoing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Point","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M B","family":"El Abassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gallien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Chaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Saillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Couffin-Cadiergues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Madelaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gibowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"key\n\t\t\t\t20180720035927_dky193-B1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/COH.0000000000000076","article-title":"Demographics of HIV and aging","volume":"9","author":"Costagliola","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180720035927_dky193-B2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1473-3099(15)70060-5","article-title":"Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study","volume":"15","author":"ENCORE1 Study Group","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180720035927_dky193-B3","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/S2352-3018(16)30010-8","article-title":"Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial","volume":"3","author":"Bunupuradah","year":"2016","journal-title":"Lancet HIV"},{"key":"key\n\t\t\t\t20180720035927_dky193-B4","year":"2017"},{"key":"key\n\t\t\t\t20180720035927_dky193-B5","author":"French National Guidelines","year":"2017"},{"key":"key\n\t\t\t\t20180720035927_dky193-B6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jac\/dku516","article-title":"Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial","volume":"70","author":"Molt\u00f3","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180720035927_dky193-B7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/jac\/dky181","article-title":"Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1 infected adults: an open-label trial (ANRS 165 Darulight)","volume":"73","author":"Molina","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180720035927_dky193-B8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/bmc.865","article-title":"Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry","volume":"21","author":"Jung","year":"2007","journal-title":"Biomed Chromatogr BMC"},{"key":"key\n\t\t\t\t20180720035927_dky193-B9","author":"EMA","year":"2010"},{"key":"key\n\t\t\t\t20180720035927_dky193-B10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/QAD.0b013e32830285fb","article-title":"Efficacy and safety of once-daily darunavir\/ritonavir versus lopinavir\/ritonavir in treatment-naive HIV-1-infected patients at week 48","volume":"22","author":"Ortiz","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180720035927_dky193-B11","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/jac\/dku193","article-title":"Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir","volume":"69","author":"Kakuda","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180720035927_dky193-B12","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/jac\/dkv439","article-title":"Simulation of the impact of rifampicin on once-daily darunavir\/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approach","volume":"71","author":"Dickinson","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180720035927_dky193-B13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e328013d9d7","article-title":"Efficacy and safety of TMC114\/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1","volume":"21","author":"Katlama","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180720035927_dky193-B14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1310\/hct0906-418","article-title":"Pharmacokinetics, efficacy, and safety of darunavir\/ritonavir 800\/100 mg once-daily in treatment-na\u00efve and -experienced patients","volume":"9","author":"Boffito","year":"2008","journal-title":"HIV Clin Trials"},{"key":"key\n\t\t\t\t20180720035927_dky193-B15","author":"L\u00ea","year":"2015"},{"key":"key\n\t\t\t\t20180720035927_dky193-B16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003088-200746090-00002","article-title":"Clinical pharmacokinetics of darunavir","volume":"46","author":"Rittweger","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20180720035927_dky193-B17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/jac\/dkw032","article-title":"Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications","volume":"71","author":"Marzolini","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180720035927_dky193-B18","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/jac\/dku131","article-title":"Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals","volume":"69","author":"Arab-Alameddine","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180720035927_dky193-B19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40262-013-0057-6","article-title":"Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients","volume":"52","author":"Molt\u00f3","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20180720035927_dky193-B20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00003088-200443090-00003","article-title":"Tenofovir disoproxil fumarate","volume":"43","author":"Kearney","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20180720035927_dky193-B21","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1128\/AAC.02058-13","article-title":"Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients","volume":"58","author":"Valade","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180720035927_dky193-B22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/135965350701200510","article-title":"Abacavir plasma pharmacokinetics in the absence and presence of atazanavir\/ritonavir or lopinavir\/ritonavir and vice versa in HIV-infected patients","volume":"12","author":"Waters","year":"2007","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180720035927_dky193-B23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.clpt.6100269","article-title":"The effect of lopinavir\/ritonavir on the renal clearance of tenofovir in HIV-infected patients","volume":"83","author":"Kiser","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20180720035927_dky193-B24","first-page":"281","article-title":"Protein content of human seminal plasma and spermatozoa in relation to sperm counts","volume":"7","author":"Singer","year":"1976","journal-title":"Acta Eur Fertil"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/8\/2120\/25178851\/dky193.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T06:58:52Z","timestamp":1661065132000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/8\/2120\/5037247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,6,13]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky193","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,6,13]]}}}